CMC development, manufacturing, quality and regulatory. Build and implement development and manufacturing strategies to bring Invetx’s transformative biotherapeutics programs to the animal health market.
20+ years of technical and leadership experience in biologics CMC development and manufacturing of novel biologics and biosimilars including cytokines, monoclonal antibodies, bispecifics, antibody drug conjugates, peptibodies, and Fc fusion proteins.
Supported 20+ IND stage programs, multiple BLA regulatory filings and successful approvals of human biotherapeutics products.
MacroGenics, NexImmune, Hospira/Pfizer and Amgen
PhD, Pharmaceutical Sciences, University of Colorado Health Sciences Center, Denver, US
BS Pharmacy, Chennai Medical College, Chennai, India
Lean Six Sigma Green Belt